Methods: 562 patients were treated at HUCH between 1987-2003, whereof 223 underwent gastrectomy with curative intent. Of these, 114p atients underwent subtotal/total gastrectomy with D1 (standard) lymphadenectomy and 109 patients had D2-3 (extended) lymph node dissection. The clinical outcome of these patients was analysed retrospectively.
INTRODUCTION
Gastric carcinoma (GCa) is one of the most common cancers worldwide (1). Despite its declining incidence, GCas till causes as ignificant proportiono f cancer deaths, being the fourth most common cause received operative treatment.Achange to amoresystematic use of D2-3 dissection took place in [1991] [1992] . The purpose of this study is to assess the clinical outcome after curativeD 1o rD 2-3 gastrectomy and to analyse whether the survival rate among the patients treated for gastric adenocarcinoma has improved by the routine use of extended lymph node dissection.
MATERIAL AND METHODS

PATIENTS
Data of patients with gastric adenocarcinoma at HUCH during 1987-2003 werec ollected and analysed. The study population consisted of 562 patients of which 295 cases with palliative treatment wereexcluded.Eighteen patients weree xcluded because the primary operation was performed in another hospital and 26 patients wereexcluded due to the fact that the curativenesso ft he treatment remained uncertain or the information was otherwise insufficient.T wo-hundred twenty three curatively operated patients wereeligible and formed the study population.
One-hundred fourteen patients had undergone traditionall ymph node dissection (D1 dissection) with subtotal or total gastrectomy(group D1) and 109 patients were treated with D2 or D3 lymph node dissection (group D2-3). Of all patients 46.2% (103 patients) werefemale and 53.8% (120 patients)male. The mean age of the patients was 63.5 years (range 30.9 -9 2.0 years). In D1 group the patients wereonanaverage five years older than patientsi nD 2-3 group (p < 0.001), and in D1 group patients had moreassociated diseases as compared to patients in D2-3 group. The morespecific data areshown in Table 1 .
SAMPLE COLLECTION AND ANALySIS
Tumour and lymph node tissue samples werec ollected at operation, fixed in formalin, embedded in paraffin and processed for histology. The histological sectionsw erea nalysed by experienced pathologists at the Department of Pathology,HUCH. Tumour locationwas established on the basis of endoscopical and peroperative findings. The location of the tumour was divided into five different categories: 1) upper part, 2) middle part, 3) lower part, 4) "stump" wherecancer had developed after partial gastric resection and 5) diffuse type wherethe tumour growth corresponded to linitis plastica-type tumour.T he tumour staging was done according to the year 2002 UICC TNM-classification (25) . TREATMENT Total or subtotal gastrectomywas performed to all patients. D1-lymph node dissections including distal or total gastrectomy, excision of greater and lesser omenta and removalof ( 26) . In extended lymph node dissection, the operating surgeon determined the extensiveness of the operation according to dissected lymph node areas in order to fulfil the criteria for D2 or D3 dissection.
FOLLOw-UP AND COMPLICATIONS
Median lengthoffollow-up was 41.7 months in D1 group and 27.5 months in D2-3 operated patients. Information regarding operation, patient survival and complications was retrieved from hospitalrecords, and the data regarding cause of death werecollected from the Finland's Office for National Statistics. Individuals alive and those deceased, whose primary cause of death diverged from gastric adenocarcinoma, wereconsidered as censored for survival analysis. blood loss, the amount of blood transfusion during operation as well as the operating time weree stablished from the patient records. Information about the postoperative stay at the hospitalwas collected and the need for intensive careo ri ntensive surveillance was recorded. Postoperative complications wereclassified into leakage, wound infections, pneumonia, pulmonary embolism, abscess, haemorrhage and other complications, i.e. sepsis or myocardial infarction. In addition, hospital mortality( postoperative death or death in 30 days after the operation) was considered as as eparate complication. The complications werefurther divided into surgical and other complications, whereof wound infection, leakage, haemorrhage, abscess and sepsis as well as hospital mortality werei ncluded in surgical complications. The incidence of these postoperativec omplicationsw eres tudiedi nD 1a nd D2-3 groups separately.
STATISTICAL METHODS
The statistical analysisw as carried out using the SPSS 11.5.1, Lead Technologies, Inc. softwares ystem. Fischer's exact probability test, Mann-whitney probability test and logistic regressiona nalysis wereu sed for determining the statistically significant relationships between postoperative complications, histopathological variables and the opera-tion extensiveness.I nt his study,ap -value <0.05 (t wosided probability) was considered as significant. In addition, Kaplan-Meier method was used for calculating the overallsurvival rates of the study population.
RESULTS
POSTOPERATIVE MORTALITy AND MORbIDITy
Four patients (3.7%) in D2-3 group and two patients (1.8%) in D1 group died within 30 dafter the operation. The difference in hospital mortality was not statistically significant (p=0.438).
In postoperative morbidity therewas astatistically significant difference between the two subgroups. In D1 group 38 patients (33.6%) had postoperative complications, while among D2-3 operated patients the number was 53 (48.6%, p=0.029). The difference between the two subgroups resulted mainly from surgical complications: 36 patients (33.0%) had surgical complicationsi nt he D2-3 group, and 19 patients (16.8%) in D1 group, p=0.008. Non-surgical complications wereequally abundant in both groups. More detailed information about postoperative morbidity is shown in Table 2 .
The median postoperative stay at the hospital was 11 d( range 3-66) among D1 operated patients, and among D2-3 operated it was 12 d( range 6-69; p= 0.012). In addition, the need for intensive carew as greater among patients having undergone extended lymph node dissection. Among D1 operated patients the mean stay at the intensive careu nit was 0.2 d, while in D2-3 group it was 1.0 d(median stay 0din both, p=0.001). Patients in D2-3 group needed intensivesurveillancefor 2.1donthe average, while in D1 group the need for intensives urveillance was 1.1 d (median 0dinboth, p=0.181).
Of the 22 patients who underwent pancreas resection, 40.9% (9 patients)had at least one surgical complication postoperatively,while the complication rate was 22.8% (45 patients) in those without pancreas resection. However, logistic regression analysis showed that the extended lymph node dissection was the only statistically significant single factor that in- Table 3 ).
SURGICAL ASPECTS
The median operation time in D2-3 operations was 4h 34 min (r ange 1h4 1m in -8h5 5m in). In D1 operationsthe median operating time was 3h 24 min, ranging from 1ht o6h5 0m in. The difference was statistically significant (p <0.001). The median blood loss among D1-operated patients was 800 ml, while it was 1200 ml in D2-3 group (p <0.001). In addition, the mean amount of blood transfusion was approximately 550 ml among patients with D2-3 gastrectomy, while it was 400 ml in D1-group (p =0.047).
SURVIVAL
The five-year survival after D1 and D2-3 lyphadenectomies is shown in different stages in the Table 4 .
DISCUSSION
The results of extended lymphadenectomy have been good in Japan: the five-year survival has been about 60-66% among curatively operated gastric cancer patients,and postoperative mortality has been less than 3% (6-7, 11, 13, 27) . In randomised European studies the results after extended lymphadenectomy have been less encouraging: the five-year survival has varied between 33 to 47% among patients having undergone extended lymphadenectomy, and no statistical differences in survival between D1 and D2 operated patients have been observed (14-15, 21, 28) . Instead, the hospital mortality has been 10-13% in D2 group, while after D1 dissection it has been 4-6% (14) (15) . On the other hand, in the German multi centrestudy,the ten-year survival was clearlyb etter among patients with stage II gastric adenocarcinomaafter D2 dissectioni nc omparison to D1 operated patients( 49.2% vs. 19 .9%) (16) . Good results from D2 dissection have been obtained also in Italy,w heret he total five-year survival was 55% and hospital mortality 3.1% after extended lymphadenectomy (17) . Recently, ar andomised study from Taiwan has demonstrated astatistically significantd ifference betweenD 1a nd D3 operated gastric cancer patients (29) . The differences in treatment results between Japan and western countries have been attempted to be explainedinterms of differences in patient materialand different stage distribution (30); on the other hand, the importance of centralizing surgery to centres with experience has been underlined in most studies. Low Maruyma index has been shown to be more important predictoro fs urvival thant he extent of lymph noded issection ( 31) . In our retrospective study,t he patientsh aving undergone extended lymphadenectomy had more postoperative complications and related to this, their need for intensive care postoperatively was greater and the median hospital stay was longer.However,inspite of moreextensive surgical operation, extended lymphadenectomy did not increase postoperative mortality significantly.In addition, ah igh overall 5-year survival (57.9%) was achieved with this method, despite the fact that the learning curve for D2-3 was included in the analysis. The numbero fp ostoperative deaths, as well as the overall complication rate, remained acceptably low in both groups. In several studies, wheret he 5-year survival after extended lymphadenectomy has been promising, the postoperative complication rate has been similar or greater than in this study (21, 28) .
Althought herew eref ew statistically significant differences between the two groups, thereweresome confoundingf actors: in many D1 gastrectomies, lymph nodes around the left gastric artery werealso excised, which makes the dissection moree xtended than the original D1 operation. In theory,t his might haveap ositive influence on survivalr ates in D1 group, and explain that no difference in survival was observed in stage II patients between the two groups. However,t his might also reduce the possibility of stage migration. In addition,t he tumour stage was not evenly distributed among D1 and D2-3 groups, and in D2-3 group thereweremorestage IV patients and less stage I patients. This might have an influence on survival rates as well, but the effect on complications is likely to be of minor importance. In our study the criteria for patientshaving undergonec urative operationw eres trict: in case of any indication that the curativeness of the operation was unsureo rc ompromised, the patient was excluded from the study population.
As aprocedure, success of extended lymphadenectomy is dependent on surgical experience and it has been estimated that the learning process, although very individual, takes 25 operations on average (32) . In our study, all (curative) D2-3 operations performed at HUCH arei ncluded, so it may be presumed that the first operations reflected the learning curve. It is to be considered that the learning curve is included in both the five-year survival analysis and postoperative morbidity.
Also, according to earlier studies, splenectomy and especially pancreas resection increase the amount of postoperativec omplications and should be avoided unless necessary (33) (34) (35) (36) . In the 1990's, when D2-3 gastrectomies werei nitiated at HUCH, pancreas resection and splenectomy werep art of extended lymphadenectomy and of the first patients having undergoneD2-3 gastrectomy,most had alsopancreas resection,splenectomy or both. Later studies showed that these procedures increase postoperative complications and might also have an egative influence on survival.Therefore, systematic use of these was abandoned. However,the early wider use of pancreas resection and splenectomy in extended lymphadenectomy might, in this study,h ave had an influence on complications, which is showed by al arger amount of postoperative complications in the D2-3 group.
In addition, thereisadistinction between Japanese and western countries regarding gastric cancer. In Finland, as well as in many other western countries, the gastric cancerp atients aret ypically aged and have multiple accompanying diseases, which predisposes to complications in surgery,while in Japan the average gastric cancer patients areyounger and otherwise healthier (30). Higher bMI may also predisposepatientsinw estern countries to poorer outcome than Japanesepatients (36) (37) (38) .
In conclusion,t he complication rate was higher among D2-3 operated patients as compared to D1 operated. However,postoperative mortality remained low in bothgroups and, in addition,and it seems that extended lympadenectomy can be performed with relatively low mortality also in Europe. Further studies areneeded to assess the value of extended lymphadenectomy in gastric cancer.
